The evaluation of efficacy of Pycnogenol® fractions on endothelial dysfunction

Acta Facultatis Pharmaceuticae Universitatis Comenianae

Volumn 60, Issue 1, 2013, Pages 7-14

  Jankyova, S ^a   Hlavackova, L ^b   Kralova, E ^a   Slazneva, J ^a   Drobna, V ^a   Zuzik, P ^a   Drafi, F ^a   Mucaji, P ^b   Eva, Racanska ^a  

^a Physics and Informatics   (Slovakia)

^b Faculty of Pharmacy   (Slovenia)

Author keywords

Diabetes; Endothelial dysfunction; Fractions; Oxidative stress; Pycnogenol mixture

Indexed keywords

EID: 84892772062     PISSN: 03012298     EISSN: 13386786     Source Type: Journal    
DOI: 10.2478/afpuc-2013-0014     Document Type: Article

References (40)

1. Belcaro G, et al. Investigation of Pycnogenol® in combination with coenzymeQ10 in heart failure patients (NYHA II/III). Panminerva Med 2010;52(2 Suppl 1):21-25.
2. Bozdag-Dundar O, et al. Synthesis of hypoglycemic activity of some new flavone derivatives. Fourth communications: 6 flavonyl-2,4-thiazolidinediones. Arzneimittelforschung 2001;51:623-627.
3. Bucala R, Tracey K., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991;87:432-438.
4. Cai H, Harrison, DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87(10):840-844.
5. Cesarone MR, et al. Improvement of diabetic microangiopathy with pycnogenol: a prospective, controlled study. Angiology 2006;57(4):431-436.
6. Cosentino F, Lüscher TF. Endothelial function in coronary artery disease. Cardiologia 1997;42(12):1221-1227.
7. Chang KS, Stevens WC. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 1992;107(4):983-990.
8. Chatterjeea A, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc Pharmacol 2008; 49(4-6):134-140.
9. Cheynier V, et al. Size separation of condensed tannins by normal phase high performance liquid chromatography. Methods Enzymol 1998;299:178-184.
10. Choudhary SK et al. Comprehensive evaluation of anti-hyperglycemic activity of fractionated Momordica charantia seed extract in alloxan-induced diabetic rats. Evid Based Complement Alternat Med 2012; doi:10.1155/2012/293650.
11. Cosentino F, et al. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997;96:25.
12. Davis BJ, et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006;55:496-505.
13. Elrod JW, et al. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arteriosc Thromb Vasc Biol 2006;26:1517-1523.
14. Fitzpatrick DF, et al. Endothelium dependent vascular effects of Pycnogenol. Cardiovascular Pharmacol 1998; 32:509-515.
15. Hamden K, et al. Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed Pharmacother 2009;63(2):95-99.
16. Hlavačková L, et al. The effect of indapamide on development of myocardial hypertrophy and fibrosis in L-NAME-induced hypertension in rat. Physiol Res 2011;60:845-852.
17. Jankyova S, et al. Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy. Pathol Res Pract 2012;208(8):452-457.
18. Jankyova S, et al. Pycnogenol efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytother Res 2009;23(8):1169-1174.
19. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radical Biol Med. 2006;40:183-192.
20. Kasiviswanath R, Ramesh A, Kumar KE. Hypoglycemic and antihyperglycemic effect of Gmelina asiatica Linn in normal and in alloxan induced diabetic rats. Biol Pharm Bull 2005;28(4):729-732.
21. Klimas J. et al. Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats. Phytother Res 2010;24(7):969-974.
22. Kolacek M, et al. Effect of natural polyphenols, pycnogenol® on superoxide dismutase and nitric oxide synthase in diabetic rats. Prague Med Rep 2010;111(4):279-288.
23. Krenek P, et al. Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol 2006;84(12):1245-1250.
24. Lin KY, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002;106:987.
25. Lin LY, et al. Up-regulation of the association between heat shock protein 90 and endothelial nitric oxide synthase prevents high glucose-induced apoptosis in human endothelial cells. J Cell Biochem 2005;94:194-201.
26. Liu X, Zhou HJ, Rohdewald P. French maritime pine bark extract pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 2004;27:893-896.
27. Maiti R, Das UK, Ghosh D. Attenuation of hyperlycemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tarmarindus indica. Biol Pharm Bull 2005;28:1172-1176.
28. Maritim A, Sanders RA, Watkins JB III. Oxidative stress and diabetic complications: a review. J Biochem Mol Toxicol 2003;17:24-48.
29. Packer L, et al. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radical Biol Med. 1999;27:704-724.
30. Parveen K, et al. Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 2010;186(2):219-227.
31. Pieper GM, et al. Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia 1997;40:910.
32. Rosei EA, Rizzoni D. Small artery remodelling in diabetes. J Cell Mol Med 2010;14(5):1030-1036.
33. Ryan EA, Pick ME, Marceau C. Use of alternative medicines in diabetes mellitus. Diabetic Med 2001;18(3):242-245.
34. Schäfer A, Högger P. Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase. Diabetes Res Clin Pract 2007;77(1):41-46.
35. Sekar, D, Sivagnanam K, Subramanian S. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats. Pharmazie 2004;60:383-387.
36. Srinivasan S, et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004;47:1727.
37. Stuard S, et al. Kidney function in metabolic syndrome may be improved with Pycnogenol®. Panminerva Med 2010;52(2 Suppl 1):27-32.
38. Virgili F, Kim D, Packer L. Procyanidins extracted from pine bark protect α-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite. FEBS Lett 1998; 431(3):315-318.
39. Wang Y, Marsden PA. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 1995;34:71-90.
40. Zibadi S, et al. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res. 2008; 28(5): 315-320.